|

|
 |
Dr. Eberhard Standl is Professor of Medicine, endocrinologist and angiologist, and presently chairman of the Munich Diabetes Research Group/Diabetes Research Institute. He graduated from the Universities of Munich and Frankfurt, and has developed his career in both Munich, and at the Joslin Diabetes Center, Boston, USA. He is retired director of the Department of Endocrinology, Diabetology and Metabolism at the Academic Hospital Munich-Schwabing.
Professor Dr. Standl's principal areas of research are diabetology, micro- and macrovascular disease, cardioneuropathy, action and degradation of insulin, and epidemiology of cardiovascular diabetic complications. He has published some 550 original papers, review articles, textbook chapters and monographs, and has received various scientific awards, including the Bertram award for research related to vascular disease in diabetes in 1981, the Castelli-Pedroli Prize of the European Association for the Study of Diabetes (EASD) in 1999, the Harold Rifkin Award of the American Diabetes Association 2005, and the Albert Renold Medal of EASD 2006. He is a member of several scientific associations, with strong affiliations to the German Diabetes Association, the EASD, and the International Diabetes Federation (IDF). He was president of the German Diabetes Association 1988/89, vice-president both of EASD and IDF 2003 to 2006 and chairman of the Organizing Committee for the EASD congress 2004 in Munich. He is head of the Diabetes Section of the German Association of Angiology, vicechair of the newly founded EASD study group on cardiovascular complications and presently serves as President of the German Diabetes Union and President of IDF Europe.
|